These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. GTP-cyclohydrolase deficiency responsive to sapropterin and 5-HTP supplementation: relief of treatment-refractory depression and suicidal behaviour. Pan L; McKain BW; Madan-Khetarpal S; Mcguire M; Diler RS; Perel JM; Vockley J; Brent DA BMJ Case Rep; 2011 Jun; 2011():. PubMed ID: 22691588 [TBL] [Abstract][Full Text] [Related]
66. Anaesthesia for caesarean section in a patient with dopa-responsive dystonia or Segawa's syndrome. Sinha A; Hartsilver EL Int J Obstet Anesth; 2009 Jan; 18(1):67-72. PubMed ID: 19022657 [TBL] [Abstract][Full Text] [Related]
67. Dopa-responsive dystonia revisited: diagnostic delay, residual signs, and nonmotor signs. Tadic V; Kasten M; Brüggemann N; Stiller S; Hagenah J; Klein C Arch Neurol; 2012 Dec; 69(12):1558-62. PubMed ID: 22986512 [TBL] [Abstract][Full Text] [Related]
68. Levodopa in the early treatment of Parkinson's disease. Murata M Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S17-20. PubMed ID: 19131036 [TBL] [Abstract][Full Text] [Related]
69. Dopa-responsive dystonia (Segawa disease) -like disease accompanied by mental retardation: a case report. Nagata E; Kosakai A; Tanaka K; Segawa M; Fujioka H; Shintaku H; Suzuki N Mov Disord; 2007 Jun; 22(8):1202-3. PubMed ID: 17469209 [No Abstract] [Full Text] [Related]
70. L-dopa-responsive infantile hypokinetic rigid parkinsonism due to tyrosine hydroxylase deficiency. de Rijk-Van Andel JF; Gabreëls FJ; Geurtz B; Steenbergen-Spanjers GC; van Den Heuvel LP; Smeitink JA; Wevers RA Neurology; 2000 Dec; 55(12):1926-8. PubMed ID: 11134401 [TBL] [Abstract][Full Text] [Related]
71. [Identification of the causative gene for Segawa's disease]. Ichinose H; Nagatsu T Rinsho Shinkeigaku; 2007 Nov; 47(11):735-8. PubMed ID: 18210787 [TBL] [Abstract][Full Text] [Related]
72. l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. Picconi B; Paillé V; Ghiglieri V; Bagetta V; Barone I; Lindgren HS; Bernardi G; Angela Cenci M; Calabresi P Neurobiol Dis; 2008 Feb; 29(2):327-35. PubMed ID: 17997101 [TBL] [Abstract][Full Text] [Related]
73. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease. Kum WF; Gao J; Durairajan SS; Man SC; Xie LX; Lu JH; Fong WL; Li M J Clin Neurosci; 2009 Aug; 16(8):1034-7. PubMed ID: 19428256 [TBL] [Abstract][Full Text] [Related]